Guidelines for breast screening mammography should take into account patient-specific risk factors to garner more cost-effective screening, with payors standing to gain from suggesting markedly less frequent screening for lower-risk women, argued the authors of a study published July 4 in the Annals of Internal Medicine.

Vasomedical has received FDA market clearance for two new monitors: the Biox Model 1303 3-channel ECG Holter Monitor and Model 1304 12-channel ECG Holter Monitor. 

New FDA regulations provide investigational new drug (IND) applicants clearer guidance on whether to report adverse events that might not have been related to a clinical trial, according to a perspective published June 8 by the New England Journal of Medicine (NEJM).

The Centers for Medicare & Medicaid Services (CMS) is asking for comments about a proposed rule that would modify certain parts of the Electronic Prescribing (eRx) Incentive Program, which uses incentive payments and payment adjustments to encourage the use of e-prescribing systems.

Eckert & Ziegler, a German-based isotope company, has acquired the radiopharmaceutical equipment business of Washington, D.C.-based Bioscan.

Florida Hospital Memorial Medical Centers Imaging Center now is offering sodium fluoride (NaF) PET/CT for bone imaging.

SAN ANTONIOAccording to the Centers for Medicare & Medicaid Services (CMS), all non-hospital providers of advanced diagnostic imaging, inclusive of nuclear medicine, MR, CT and PET, must obtain accreditation as a condition for reimbursement by Jan. 1, 2012. Just who is authorized to offer such accreditation was the subject of a June 26 afternoon presentation at the 2011 Association for the Advancement of Medical Instrumentation (AAMI) conference & expo.

Candu Energy, a wholly owned subsidiary of SNC-Lavalin Group, has agreed with the Government of Canada to acquire certain assets of Atomic Energy of Canadas (AECL) commercial reactor division for a purchase price of CAD15 million (USD $15.59 million) and royalty payments from future new build and life extension projects. AECL will retain its past liabilities.